The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

Bibliographic Details
Main Authors:	Christine G Maure, Alexander N Dodoo, Jan Bonhoeffer, Patrick LF Zuber
Format:	Article
Language:	English
Published:	The World Health Organization 2014-09-01
Series:	Bulletin of the World Health Organization
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862014000900016&lng=en&tlng=en

Similar Items

Evolving pharmacovigilance requirements with novel vaccines and vaccine components
by: Patrick L F Zuber, et al.
Published: (2021-05-01)

Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project
by: Apoorva Sharan, et al.
Published: (2022-08-01)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
by: Annette Rudolph, et al.
Published: (2022-08-01)

Unveiling vaccine safety: a narrative review of pharmacovigilance in India's COVID-19 vaccination
by: Megha Hegde, et al.
Published: (2023-12-01)

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences
by: H. Hilda Ampadu, et al.
Published: (2018-11-01)

Safety of routine childhood vaccine coadministration versus separate vaccination
by: Simon de Lusignan, et al.
Published: (2022-09-01)

Global burden of vaccine-associated kidney injury using an international pharmacovigilance database
by: Hyeon Seok Hwang, et al.
Published: (2025-02-01)

National immunization program: vaccination, compliance and pharmacovigilance
by: Carla Magda Allan S. Domingues, et al.
Published: (2012-10-01)

Safety of routine childhood vaccine coadministration versus separate vaccination
by: Bauwens, J, et al.
Published: (2022)

Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
by: Denise Naniche, et al.
Published: (2021-06-01)

Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries.
by: Sanjana Mukherjee, et al.
Published: (2023-01-01)

Pharmacovigilance in the vaccination program against coronavirus disease 19
by: Octavio Amancio-Chassin
Published: (2021-07-01)

Vienna Vaccine Safety Initiative
by: Barbara Rath
Published: (2018-05-01)

Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities.
by: Nyasha Bakare, et al.
Published: (2011-07-01)

The Post-Acute COVID-19-Vaccination Syndrome in the Light of Pharmacovigilance
by: Barbara Platschek, et al.
Published: (2024-12-01)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
by: Khontile Nobuhle Kunene, et al.
Published: (2023-05-01)

Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review
by: Jorgen Bauwens, et al.
Published: (2019-12-01)

Vaccine safety issues at the turn of the 21st century
by: Andrew J Pollard, et al.
Published: (2021-05-01)

Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data
by: Raphael Battegay, et al.
Published: (2021-12-01)

Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
by: Katharine Valéria Saraiva Hodel, et al.
Published: (2024-06-01)

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
by: Fotini Boufidou, et al.
Published: (2023-03-01)

Pharmacovigilance: the evolution of drug safety monitoring
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024-12-01)

Big data, medicines safety and pharmacovigilance
by: Rabia Hussain
Published: (2021-12-01)

Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
by: Jaehyeong Cho, et al.
Published: (2024-09-01)

Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
by: Ambrose O. Isah, et al.
Published: (2023-07-01)

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
by: Rosanna Ruggiero, et al.
Published: (2023-05-01)

Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
by: Dan K Kajungu, et al.
Published: (2014-01-01)

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.
by: Ward, SA, et al.
Published: (2007)

Pharmacovigilance: Boon for the safety and efficacy of ayuvedic formulations
by: Anand Chaudhary, et al.
Published: (2010-01-01)

Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase)
by: Sun-Young Jung, et al.
Published: (2023-07-01)

Vaccine safety issues at the turn of the 21st century
by: Conklin, L, et al.
Published: (2021)

A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database
by: Huting Zhou, et al.
Published: (2025-02-01)

COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database
by: Basile Chrétien, et al.
Published: (2022-11-01)

Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward
by: Ganesh Kumraj, et al.
Published: (2022-01-01)

Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally
by: Parisa A. ShamaeiZadeh, et al.
Published: (2024-06-01)

Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators
by: Therese Hesketh, et al.
Published: (2021-09-01)

Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis.
by: Megan Auzenbergs, et al.
Published: (2024-04-01)

Safety of oral cholera vaccines during pregnancy in developing countries
by: Ashraful Islam Khan, et al.
Published: (2017-10-01)

Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
by: Huqun Li, et al.
Published: (2025-01-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)